Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Reviews in Cardiovascular Medicine|July 14, 2021
Impact of the COVID-19 pandemic on the management of chronic heart failureMelanie McGinlay, Sam Straw, Jacob Jagger, et al.
BMJ Supportive & Palliative Care|June 26, 2024
The Surprise Question and clinician-predicted prognosis: systematic review and meta-analysisAnkit Gupta, Ruth Burgess, Michael Drozd, et al.
The Journal of Cardiovascular Nursing|July 29, 2021
Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?Melanie McGinlay, Sam Straw, Rowenna Byrom-Goulthorp, et al.
ESC Heart Failure|August 7, 2020
Prioritizing symptom management in the treatment of chronic heart failureAaron O Koshy, Elisha R Gallivan, Melanie McGinlay, et al.
The British Journal of Cardiology|September 26, 2024
Inpatient initiation of sodium-glucose cotransporter-2 inhibitors: the prescribing learning curveHiba F Hammad, Charlotte Gross, Thomas A Slater, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 14, 2021
Impact of QRS duration on left ventricular remodelling and survival in patients with heart failureSam Straw, Melanie McGinlay, John Gierula, et al.
ESC Heart Failure|July 7, 2022
Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomesVictoria Palin, Michael Drozd, Ellis Garland, et al.
ESC Heart Failure|September 14, 2020
Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fractionSam Straw, Melanie McGinlay, Samuel D Relton, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 5, 2022
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fractionSam Straw, Charlotte A Cole, Melanie McGinlay, et al.
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
Pageof 6